Beijing Scitop Bio-Tech Co., Ltd. (300858) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Beijing Scitop Bio-Tech Co., Ltd.

Why is Beijing Scitop Bio-Tech Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 1.04% and Operating profit at -4.26% over the last 5 years

With a growth in Net Sales of 28.98%, the company declared Very Positive results in Sep 25

RAW MATERIAL COST(Y) Fallen by -14.34% (YoY)
CASH AND EQV(HY) Highest at CNY 1,690.55 MM
INVENTORY TURNOVER RATIO(HY) Highest at 3.93 times

With ROE of 5.06%, it has a expensive valuation with a 2.56 Price to Book Value

Over the past year, while the stock has generated a return of 42.44%, its profits have fallen by -5.9%

Market Beating Performance

The stock has generated a return of 42.44% in the last 1 year, much higher than market (China Shanghai Composite) returns of 16.01%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Beijing Scitop Bio-Tech Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Beijing Scitop Bio-Tech Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Beijing Scitop Bio-Tech Co., Ltd.

42.44%

0.38

58.73%

China Shanghai Composite

16.01%

1.07

14.97%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

1.04%

EBIT Growth (5y)

-4.26%

EBIT to Interest (avg)

86.97

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.51

Sales to Capital Employed (avg)

0.18

Tax Ratio

14.14%

Dividend Payout Ratio

41.89%

Pledged Shares

Institutional Holding

ROCE (avg)

13.24%

ROE (avg)

7.69%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.56

EV to EBIT

50.71

EV to EBITDA

35.07

EV to Capital Employed

4.05

EV to Sales

11.49

PEG Ratio

Dividend Yield

0.86%

ROCE (Latest)

7.98%

ROE (Latest)

5.06%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -14.34% (YoY

CASH AND EQV(HY)

Highest at CNY 1,690.55 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 3.93 times

NET SALES(Q)

Highest at CNY 104.04 MM

OPERATING PROFIT(Q)

Highest at CNY 30.44 MM

PRE-TAX PROFIT(Q)

Highest at CNY 38.16 MM

NET PROFIT(Q)

Highest at CNY 34.59 MM

EPS(Q)

Highest at CNY 0.13

-3What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 107.06 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 29.25 %

Here's what is working for Beijing Scitop Bio-Tech Co., Ltd.

Net Sales

Highest at CNY 104.04 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 104.04 MM has Grown at 28.98%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 30.44 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Pre-Tax Profit

Highest at CNY 38.16 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 34.59 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.13

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv

Highest at CNY 1,690.55 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio

Highest at 3.93 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -14.34% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Beijing Scitop Bio-Tech Co., Ltd.

Operating Cash Flow

Lowest at CNY 107.06 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit Margin

Lowest at 29.25 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales